Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 20 and up

Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair

Official title: Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair: A Randomized, Single-blind, Controlled Clinical Trial

Run by Seoul National University Hospital · NCT07806006 · Data updated 2026-11-12

This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages20 Years and up
SexAll
Enrollment44 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedSeptember 15, 2027
Study endsOctober 30, 2027
Registry record updatedOctober 29, 2026
Trial IDNCT07806006 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 and older scheduled for TEVAR or EVAR under general anesthesia at Seoul National University Hospital.

Probably not a fit

Patients with contraindications to either study drug or those not undergoing TEVAR/EVAR may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind study compares two IV anesthetics—remimazolam besylate and propofol—in adults undergoing thoracic or abdominal endovascular aortic repair. The trial looks at intraoperative hemodynamic stability by measuring vasopressor needs during surgery. The goal is to determine which anesthetic produces fewer blood pressure fluctuations and less vasopressor support in high-risk patients. Findings could guide anesthetic choice to improve organ perfusion during these procedures.

Why it matters

Potential benefit: If remimazolam proves more stable, patients may experience fewer blood pressure swings and less vasopressor use during surgery.

How similar studies have gone: Limited direct comparisons exist for these agents in this surgical context, making this study one of the first to address hemodynamic stability with these drugs in endovascular aortic procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Adults aged 20 years or older scheduled for thoracic or abdominal endovascular aortic repair (TEVAR/EVAR) under general anesthesia for thoracic or abdominal aortic aneurysm

Exclusion Criteria:

* Known or suspected allergy or hypersensitivity to the study drugs
* ASA physical status class IV or higher
* Body mass index (BMI) ≥ 30 kg/m\^2
* Chronic use of opioids or benzodiazepines
* History of alcohol or drug abuse
* Preoperative cognitive impairment
* Severe left ventricular dysfunction (left ventricular ejection fraction \< 40%)
* Severe hepatic dysfunction (Child-Pugh class C)
* Severe hypoalbuminemia (\< 2.0 g/dL)
* Acute or chronic renal failure requiring dialysis
* Pregnancy or breastfeeding
* Emergency procedure

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.